Compositions derived from modiolus modiolus and methods for making and using same
CA 2403671 A1 · Owner: Sfs, Inc. · Inventors: Collin, Peter D.; Adrian, Thomas E.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed are compositions which include an isolated soft tissue from Modiolus modiolus ("MM") and compositions which include an oil isolated from MM or a portion thereof. Also disclosed are methods of treating adenocarcinoma in a subject; methods of decreasing proliferation of adenocarcinoma cells or of , inducing apoptosis of adenocarcinoma cells or of inducing differentiation of , adenocarcinoma cells into non-cancerous cells; methods of inhibiting the activity of 5-lipoxygenase or 12-lipoxygenase or both in cells; and methods of treating a subject suffering from a disease or condition associated with excessive 5-lipoxygenase activity or 12-lipoxygenase activity or both. A process …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 22, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 22, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 22, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.